Micro Emerging Active

Morgan Stanley améliore ses prévisions pour GILD sur la base de modèles de biopharmacie mis à jour.

New narrative with limited coverage — still forming.

Score
0,5
Vélocité
▲ 1,0
Articles
2
Sources
1

Sentiment Timeline

Event Timeline

Avr 17, 2026
Jim Cramer on Gilead Sciences: “I’d Hold On to It” Bullish
Avr 15, 2026
Morgan Stanley Boosts Gilead (GILD) Outlook on Updated Biopharma Models Neutral

Articles Liés

Jim Cramer on Gilead Sciences: “I’d Hold On to It”

Yahoo Finance · Avr 17, 2026
Mixed

Chronologie

Dernière mise à jourAvr 15, 2026